FinnCap Reaffirms Buy Rating for Abzena PLC (ABZA)
Abzena PLC (LON:ABZA)‘s stock had its “buy” rating reiterated by FinnCap in a note issued to investors on Tuesday. They presently have a GBX 70 ($0.92) target price on the stock. FinnCap’s price objective would suggest a potential upside of 117.05% from the company’s previous close.
Separately, Numis Securities Ltd restated a “buy” rating and issued a GBX 80 ($1.05) price target on shares of Abzena PLC in a research report on Thursday, September 14th.
Shares of Abzena PLC (LON:ABZA) remained flat at $GBX 32.25 ($0.42) during trading hours on Tuesday. Abzena PLC has a 52 week low of GBX 27.73 ($0.36) and a 52 week high of GBX 66 ($0.87).
Abzena plc is a life sciences company. The Company provides technologies and complementary services to enable the development and manufacture of biopharmaceutical products. It has a global customer base which includes approximately 20 biopharmaceutical companies, as well as large and small biotech companies and academic groups.
Receive News & Ratings for Abzena PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abzena PLC and related companies with MarketBeat.com's FREE daily email newsletter.